Completed NA INTERVENTIONAL 3-arm NCT00428246

Study of Protective Effects of Paricalcitol on Inner Layer of Vessels and Its Protective Effect on Inflammation

Anti-Inflammatory and Endothelial Protectant Effects of Paricalcitol

Sponsor: Abbott

Conditions Chronic Kidney Disease Endothelial Dysfunction Hypertension Inflammation

Updated 5 times since 2017 Last updated: Apr 6, 2009 Started: Nov 30, 2006 Primary completion: Jul 31, 2007 Completion: Jul 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00428246, this NA trial focuses on Chronic Kidney Disease and Endothelial Dysfunction and remains completed. Sponsored by Abbott, it has been updated 5 times since 2006, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Nov 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Abbott
Indiana University School of Medicine

Data source: Indiana University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Indianapolis, United States